FDA inspection
Miguel A. Mujica Baella M.D.: FDA inspection ending Feb 20, 2025
FDA inspection 1262111 · Official Action Indicated (OAI) · Cutler Bay, FL
Key facts
| Inspection ID | 1262111 |
|---|---|
| Firm | Miguel A. Mujica Baella M.D. |
| FEI number | 3033552902 |
| Address | Advanced Pharma Research Inc, 10700 Caribbean Blvd Ste 304 |
| City | Cutler Bay |
| State | FL |
| ZIP | 33189 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Feb 20, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data